Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Effect of fiberglass orientation on flexural properties of fiberglass-reinforced composite resin block for CAD/CAM.

Yasue T, Iwasaki N, Shiozawa M, Tsuchida Y, Suzuki T, Takahashi H.

Dent Mater J. 2019 Jun 21. doi: 10.4012/dmj.2018-249. [Epub ahead of print]

2.

Recovery of quantum efficiency in spin-polarized photocathodes by atomic hydrogen cleaning.

Jin X, Suzuki M, Yasue T, Koshikawa T, Takeda Y.

Ultramicroscopy. 2017 Dec;183:89-93. doi: 10.1016/j.ultramic.2017.03.033. Epub 2017 Mar 30.

PMID:
28410772
3.

Vascular Endothelial Growth Factor in Plasma and Pleural Effusion Is a Biomarker for Outcome After Bevacizumab plus Carboplatin-Paclitaxel Treatment for Non-small Cell Lung Cancer with Malignant Pleural Effusion.

Tamiya M, Tamiya A, Yasue T, Nakao K, Omachi N, Shiroyama T, Tani E, Hamaguchi M, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Hirashima T.

Anticancer Res. 2016 Jun;36(6):2939-44.

PMID:
27272808
4.

Evaluation of the shear bond strength of dental porcelain and the low magnetic susceptibility Zr-14Nb alloy.

Kajima Y, Takaichi A, Yasue T, Doi H, Takahashi H, Hanawa T, Wakabayashi N.

J Mech Behav Biomed Mater. 2016 Jan;53:131-141. doi: 10.1016/j.jmbbm.2015.08.008. Epub 2015 Aug 13.

PMID:
26318573
5.

Novel multipole Wien filter as three-dimensional spin manipulator.

Yasue T, Suzuki M, Tsuno K, Goto S, Arai Y, Koshikawa T.

Rev Sci Instrum. 2014 Apr;85(4):043701. doi: 10.1063/1.4870249.

PMID:
24784612
6.

Magnetic domain patterns on strong perpendicular magnetization of Co/Ni multilayers as spintronics materials: I. Dynamic observations.

Suzuki M, Kudo K, Kojima K, Yasue T, Akutsu N, Diño WA, Kasai H, Bauer E, Koshikawa T.

J Phys Condens Matter. 2013 Oct 9;25(40):406001. doi: 10.1088/0953-8984/25/40/406001. Epub 2013 Sep 11.

PMID:
24025861
7.

Magnetic domain patterns on strong perpendicular magnetization of Co/Ni multilayers as spintronics materials: II. Numerical simulations.

Kudo K, Suzuki M, Kojima K, Yasue T, Akutsu N, Diño WA, Kasai H, Bauer E, Koshikawa T.

J Phys Condens Matter. 2013 Oct 2;25(39):395005. doi: 10.1088/0953-8984/25/39/395005. Epub 2013 Sep 9.

PMID:
24013171
8.

Phosphodiesterase inhibitors. Part 6: design, synthesis, and structure-activity relationships of PDE4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory activity.

Kojima A, Takita S, Sumiya T, Ochiai K, Iwase K, Kishi T, Ohinata A, Yageta Y, Yasue T, Kohno Y.

Bioorg Med Chem Lett. 2013 Oct 1;23(19):5311-6. doi: 10.1016/j.bmcl.2013.07.069. Epub 2013 Aug 8.

PMID:
23988356
9.

Phase2 study of bevacizumab with carboplatin-paclitaxel for non-small cell lung cancer with malignant pleural effusion.

Tamiya M, Tamiya A, Yamadori T, Nakao K, Asami K, Yasue T, Otsuka T, Shiroyama T, Morishita N, Suzuki H, Okamoto N, Okishio K, Kawaguchi T, Atagi S, Kawase I, Hirashima T.

Med Oncol. 2013;30(3):676. doi: 10.1007/s12032-013-0676-7. Epub 2013 Aug 8.

PMID:
23925664
10.

Distribution of radioactive cesium in edible parts of cattle.

Okada K, Sato I, Deguchi Y, Morita S, Yasue T, Yayota M, Takeda K, Sato S.

Anim Sci J. 2013 Dec;84(12):798-801. doi: 10.1111/asj.12075. Epub 2013 May 3.

PMID:
23638759
11.

Comparative effect of candesartan and amlodipine, and effect of switching from valsartan, losartan, telmisartan and olmesartan to candesartan, on early morning hypertension and heart rate.

Minatoguchi S, Aoyama T, Kawai N, Iwasa M, Oda M, Kida K, Kojima S, Goto N, Goto M, Sugishita F, Takai K, Tanaka R, Hiei K, Minagawa T, Yamamoto N, Watanabe I, Yasue T, Kobayashi H.

Blood Press. 2013 Sep;22 Suppl 1:29-37. doi: 10.3109/08037051.2013.757844. Epub 2013 Jan 18.

PMID:
23330658
12.

Phosphodiesterase inhibitors. Part 5: hybrid PDE3/4 inhibitors as dual bronchorelaxant/anti-inflammatory agents for inhaled administration.

Ochiai K, Takita S, Kojima A, Eiraku T, Iwase K, Kishi T, Ohinata A, Yageta Y, Yasue T, Adams DR, Kohno Y.

Bioorg Med Chem Lett. 2013 Jan 1;23(1):375-81. doi: 10.1016/j.bmcl.2012.08.121. Epub 2012 Nov 9.

PMID:
23200255
13.

Ibudilast, a phosphodiesterase inhibitor, in combination with low-dose aspirin potently inhibits guinea pig carotid artery thrombosis without extending bleeding time and causing gastric mucosal injury.

Matsuzawa S, Hoshina K, Sueyoshi S, Miyata Y, Manita S, Ooie T, Yasue T, Sasahara T.

Arzneimittelforschung. 2012 Dec;62(12):545-53. doi: 10.1055/s-0032-1323699. Epub 2012 Sep 3.

PMID:
22945770
14.

Residual-density mapping and site-selective determination of anomalous scattering factors to examine the origin of the Fe K pre-edge peak of magnetite.

Okube M, Yasue T, Sasaki S.

J Synchrotron Radiat. 2012 Sep;19(Pt 5):759-67. doi: 10.1107/S0909049512031147. Epub 2012 Aug 3.

PMID:
22898955
15.

Phosphodiesterase inhibitors. Part 4: design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-4,4-dimethylpyrazolones.

Ochiai K, Takita S, Kojima A, Eiraku T, Ando N, Iwase K, Kishi T, Ohinata A, Yageta Y, Yasue T, Adams DR, Kohno Y.

Bioorg Med Chem Lett. 2012 Sep 15;22(18):5833-8. doi: 10.1016/j.bmcl.2012.07.088. Epub 2012 Jul 31.

PMID:
22884989
16.

Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.

Tamiya M, Kobayashi M, Morimura O, Yasue T, Nakasuji T, Satomu M, Kohei O, Takayuki S, Morishita N, Suzuki H, Sasada S, Okamoto N, Hirashima T, Kawase I.

Clin Lung Cancer. 2013 Jan;14(1):50-4. doi: 10.1016/j.cllc.2012.03.012. Epub 2012 May 18.

PMID:
22609050
17.

Phosphodiesterase inhibitors. Part 3: Design, synthesis and structure-activity relationships of dual PDE3/4-inhibitory fused bicyclic heteroaromatic-dihydropyridazinones with anti-inflammatory and bronchodilatory activity.

Ochiai K, Takita S, Eiraku T, Kojima A, Iwase K, Kishi T, Fukuchi K, Yasue T, Adams DR, Allcock RW, Jiang Z, Kohno Y.

Bioorg Med Chem. 2012 Mar 1;20(5):1644-58. doi: 10.1016/j.bmc.2012.01.033. Epub 2012 Jan 28.

PMID:
22336247
18.

Carbocisteine promotes phagocytosis of apoptotic cells by alveolar macrophages.

Inoue M, Ishibashi Y, Nogawa H, Yasue T.

Eur J Pharmacol. 2012 Feb 29;677(1-3):173-9. doi: 10.1016/j.ejphar.2011.12.026. Epub 2011 Dec 27.

PMID:
22222820
19.

Phosphodiesterase inhibitors. Part 2: design, synthesis, and structure-activity relationships of dual PDE3/4-inhibitory pyrazolo[1,5-a]pyridines with anti-inflammatory and bronchodilatory activity.

Ochiai K, Ando N, Iwase K, Kishi T, Fukuchi K, Ohinata A, Zushi H, Yasue T, Adams DR, Kohno Y.

Bioorg Med Chem Lett. 2011 Sep 15;21(18):5451-6. doi: 10.1016/j.bmcl.2011.06.118. Epub 2011 Jul 2.

PMID:
21764304
20.

Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.

Tamiya M, Suzuki H, Kobayashi M, Sasada S, Okamoto N, Morishita N, Yasue T, Matsuura Y, Hirashima T, Kawase I.

Med Oncol. 2012 Mar;29(1):215-8. doi: 10.1007/s12032-010-9801-z. Epub 2011 Jan 22.

PMID:
21258879
21.

Anterior shift in gene expression precedes anteriormost digit formation in amniote limbs.

Uejima A, Amano T, Nomura N, Noro M, Yasue T, Shiroishi T, Ohta K, Yokoyama H, Tamura K.

Dev Growth Differ. 2010 Feb;52(2):223-34. doi: 10.1111/j.1440-169X.2009.01161.x. Epub 2010 Jan 20.

PMID:
20100248
22.

Step contrast reversal in LEEM during Pb deposition on W(110).

Yasue T, Amakawa R, Shimizu H, Nakaguchi A, Koshikawa T, Bauer E.

J Phys Condens Matter. 2009 Aug 5;21(31):314024. doi: 10.1088/0953-8984/21/31/314024. Epub 2009 Jul 7.

PMID:
21828585
23.

Magnetic field switching between the two orbital-ordered states in DyVO3.

Miyasaka S, Yasue T, Fujioka J, Yamasaki Y, Okimoto Y, Kumai R, Arima T, Tokura Y.

Phys Rev Lett. 2007 Nov 23;99(21):217201. Epub 2007 Nov 19.

PMID:
18233244
24.

A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.

Song J, Matsuda C, Kai Y, Nishida T, Nakajima K, Mizushima T, Kinoshita M, Yasue T, Sawa Y, Ito T.

J Pharmacol Exp Ther. 2008 Jan;324(1):276-83. Epub 2007 Sep 26.

PMID:
17898319
25.

A novel sphingosine-1-phosphate receptor agonist KRP-203 attenuates rat autoimmune myocarditis.

Ogawa R, Takahashi M, Hirose S, Morimoto H, Ise H, Murakami T, Yasue T, Kuriyama K, Hongo M, Kobayashi E, Ikeda U.

Biochem Biophys Res Commun. 2007 Sep 28;361(3):621-8. Epub 2007 Jul 23.

PMID:
17673173
26.

Characterization of spectroscopic photoemission and low energy electron microscope using multipolarized soft x rays at BL17SU/SPring-8.

Guo FZ, Muro T, Matsushita T, Wakita T, Ohashi H, Senba Y, Kinoshita T, Kobayashi K, Saitoh Y, Koshikawa T, Yasue T, Oura M, Takeuchi T, Shin S.

Rev Sci Instrum. 2007 Jun;78(6):066107.

PMID:
17614651
27.

Use of sphingosine-1-phosphate 1 receptor agonist, KRP-203, in combination with a subtherapeutic dose of cyclosporine A for rat renal transplantation.

Fujishiro J, Kudou S, Iwai S, Takahashi M, Hakamata Y, Kinoshita M, Iwanami S, Izawa S, Yasue T, Hashizume K, Murakami T, Kobayashi E.

Transplantation. 2006 Sep 27;82(6):804-12.

PMID:
17006328
28.

Change from cyclosporine to combination therapy of mycophenolic acid with the new sphingosine-1-phosphate receptor agonist, KRP-203, prevents host nephrotoxicity and transplant vasculopathy in rats.

Fujishiro J, Suzuki C, Kudou S, Yasue T, Hakamata Y, Takahashi M, Murakami T, Hashizume K, Kobayashi E.

J Heart Lung Transplant. 2006 Jul;25(7):825-33. Epub 2006 Jun 5.

PMID:
16818126
29.

Sphingosine-1-phosphate receptor agonists suppress concanavalin A-induced hepatic injury in mice.

Kaneko T, Murakami T, Kawana H, Takahashi M, Yasue T, Kobayashi E.

Biochem Biophys Res Commun. 2006 Jun 23;345(1):85-92. Epub 2006 Apr 25.

PMID:
16674913
30.

A novel immunomodulator KRP-203 combined with cyclosporine prolonged graft survival and abrogated transplant vasculopathy in rat heart allografts.

Takahashi M, Shimizu H, Murakami T, Enosawa S, Suzuki C, Takeno Y, Hakamata Y, Kudou S, Izawa S, Yasue T, Kobayashi E.

Transplant Proc. 2005 Jan-Feb;37(1):143-5.

PMID:
15808575
31.

KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.

Shimizu H, Takahashi M, Kaneko T, Murakami T, Hakamata Y, Kudou S, Kishi T, Fukuchi K, Iwanami S, Kuriyama K, Yasue T, Enosawa S, Matsumoto K, Takeyoshi I, Morishita Y, Kobayashi E.

Circulation. 2005 Jan 18;111(2):222-9. Epub 2005 Jan 10.

PMID:
15642767
32.

Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma.

Matsuo K, Hamajima N, Suzuki R, Ogura M, Kagami Y, Taji H, Yasue T, Mueller NE, Nakamura S, Seto M, Morishima Y, Tajima K.

Am J Hematol. 2004 Dec;77(4):351-7.

33.

Combination of short-pulsed CO2 laser resurfacing and cultured epidermal sheet autografting in the treatment of vitiligo: a preliminary report.

Toriyama K, Kamei Y, Kazeto T, Yasue T, Suga Y, Inoie M, Tomita Y, Torii S.

Ann Plast Surg. 2004 Aug;53(2):178-80.

PMID:
15269591
34.

Gene-environment interactions between the smoking habit and polymorphisms in the DNA repair genes, APE1 Asp148Glu and XRCC1 Arg399Gln, in Japanese lung cancer risk.

Ito H, Matsuo K, Hamajima N, Mitsudomi T, Sugiura T, Saito T, Yasue T, Lee KM, Kang D, Yoo KY, Sato S, Ueda R, Tajima K.

Carcinogenesis. 2004 Aug;25(8):1395-401. Epub 2004 Mar 25.

PMID:
15044328
35.
36.

Essential role of Stat5 for IL-5-dependent IgH switch recombination in mouse B cells.

Horikawa K, Kaku H, Nakajima H, Davey HW, Hennighausen L, Iwamoto I, Yasue T, Kariyone A, Takatsu K.

J Immunol. 2001 Nov 1;167(9):5018-26.

37.

A survey of filling methods, intracanal medications, and instrument breakage.

Itoh A, Higuchi N, Minami G, Yasue T, Yoshida T, Maseki T, Nakamura H.

J Endod. 1999 Dec;25(12):823-4.

PMID:
10726530
38.

IgG1 production by sIgD+ splenic B cells and peritoneal B-1 cells in response to IL-5 and CD38 ligation.

Yasue T, Baba M, Mori S, Mizoguchi C, Uehara S, Takatsu K.

Int Immunol. 1999 Jun;11(6):915-23.

PMID:
10360965
39.

Inhibitory activities of gatifloxacin (AM-1155), a newly developed fluoroquinolone, against bacterial and mammalian type II topoisomerases.

Takei M, Fukuda H, Yasue T, Hosaka M, Oomori Y.

Antimicrob Agents Chemother. 1998 Oct;42(10):2678-81.

40.

A critical role of Lyn and Fyn for B cell responses to CD38 ligation and interleukin 5.

Yasue T, Nishizumi H, Aizawa S, Yamamoto T, Miyake K, Mizoguchi C, Uehara S, Kikuchi Y, Takatsu K.

Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10307-12.

41.

Mediastinal lipoma: report of a case.

Kato M, Saji S, Kunieda K, Yasue T, Nishio K, Adachi M.

Surg Today. 1997;27(8):766-8.

PMID:
9306596
42.

Structure and phase behaviour of dimyristoylphosphatidic acid/poly(L-lysine) systems.

Takahashi H, Yasue T, Ohki K, Hatta I.

Mol Membr Biol. 1996 Oct-Dec;13(4):233-40.

PMID:
9116762
43.
44.
45.

[Interleukin-5 (IL-5)].

Yasue T, Kikuchi Y, Takatsu K.

Nihon Rinsho. 1995 Mar;53 Su Pt 2:786-9. Review. Japanese. No abstract available.

PMID:
8753359
46.

[The genetic application for Japanese patients with coronary artery diseases using restriction fragment length polymorphisms (RFLPs) of apolipoprotein gene].

Arakawa M, Hirakawa S, Itoh H, Mori N, Yasue T, Watanabe S, Tanaka T, Uemura H, Yamaguchi M, Takaya T, et al.

Rinsho Byori. 1993 Jan;41(1):101-6. Japanese.

PMID:
8102653
47.

In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.

Hosaka M, Yasue T, Fukuda H, Tomizawa H, Aoyama H, Hirai K.

Antimicrob Agents Chemother. 1992 Oct;36(10):2108-17.

48.

Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis.

Sanda T, Yasue T, Oohashi M, Yasue A.

J Allergy Clin Immunol. 1992 Mar;89(3):653-7.

PMID:
1545086
49.

An immunoserological study of patients with vibration syndrome.

Matsumoto Y, Yasue T, Miyagawa H, Mizuno N, Yoshida I.

Int Arch Occup Environ Health. 1992;63(8):537-9.

PMID:
1587628
50.

Selective toxicity of 1-methyl-4-phenylpyridinium ion (MPP+) to pigmented melanoma cells in vitro.

Umemura T, Ohya Y, Naoi M, Nagatsu T, Fukui Y, Yasue T, Ohashi M.

Anticancer Drug Des. 1991 Jul;6(3):207-10. No abstract available.

PMID:
1872948

Supplemental Content

Support Center